Search

Search Results

2 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 13, Issue 5pp 6890-6903

  MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts

  Relevance score: 0.00

  Kaibin Zhu, Zhonghua Lv, Jinsheng Xiong, Hongshan Zheng, Sibin Zhang, Hua Jin, Lei Yu, Zhenzhe Li, Jixing Zhang, Chenlong Li, Peng Liang

  Keywords: osimertinib resistance, non-small cell lung cancer (NSCLC), cancer-associated fibroblasts (CAFs), MET associated signaling, capmatinib

  Published in Aging on February 17, 2021

  Show abstract
• EditorialVolume 16, Issue 14pp 11122-11124

  Targeted cancer therapy: the initial high concentration may slow down the selection for resistance

  Relevance score: 0.00

  Mikhail V. Blagosklonny

  Keywords: lung cancer, resistance, brain metastases, METex14, capmatinib, rapamycin

  Published in Aging on July 28, 2024

  Show abstract